USANA Health Sciences Reports Third Quarter Results

Go back to USANA Health Sciences Reports Third Quarter Results

USANA Health Sciences (USNA) Misses Q3 EPS by 14c; Lowers FY Outlook

October 25, 2022 4:13 PM EDT

USANA Health Sciences (NYSE: USNA) reported Q3 EPS of $0.78, $0.14 worse than the analyst estimate of $0.92. Revenue for the quarter came in at $233 million versus the consensus estimate of $245.95 million.

GUIDANCE:

USANA Health Sciences sees FY2022 EPS of $3.15-$3.40, versus the... More